Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SNIFFLE-3
NCT02549365Phase 4Completed
- Sponsor
- Imperial College London
- Start
- Oct 2015
- Primary completion
- Apr 2016
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of live attenuated influenza vaccine in influenza, sponsored by Imperial College London. Started Oct 2015; status: completed.
02
Drugs
live attenuated influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on NCT02549365.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02549365.